Patterson Companies, Inc. (NASDAQ:PDCO) Shares Purchased by Moran Wealth Management LLC

Moran Wealth Management LLC lifted its position in Patterson Companies, Inc. (NASDAQ:PDCO) by 4.7% during the 4th quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 114,555 shares of the company’s stock after acquiring an additional 5,167 shares during the period. Moran Wealth Management LLC owned 0.13% of Patterson Companies worth $3,535,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

Several other hedge funds and other institutional investors also recently added to or reduced their stakes in PDCO. Van ECK Associates Corp grew its position in Patterson Companies by 11.6% during the 3rd quarter. Van ECK Associates Corp now owns 72,717 shares of the company’s stock worth $1,542,000 after purchasing an additional 7,585 shares during the period. Atria Investments Inc grew its position in Patterson Companies by 10.6% during the 3rd quarter. Atria Investments Inc now owns 10,115 shares of the company’s stock worth $221,000 after purchasing an additional 973 shares during the period. Chartwell Investment Partners LLC grew its position in Patterson Companies by 32.9% during the 3rd quarter. Chartwell Investment Partners LLC now owns 359,681 shares of the company’s stock worth $7,856,000 after purchasing an additional 88,968 shares during the period. Victory Capital Management Inc. grew its position in Patterson Companies by 3.9% during the 3rd quarter. Victory Capital Management Inc. now owns 383,949 shares of the company’s stock worth $8,385,000 after purchasing an additional 14,356 shares during the period. Finally, KBC Group NV grew its position in Patterson Companies by 32.7% during the 3rd quarter. KBC Group NV now owns 2,757 shares of the company’s stock worth $60,000 after purchasing an additional 680 shares during the period. 85.43% of the stock is owned by institutional investors and hedge funds.

Analyst Ratings Changes

PDCO has been the topic of several analyst reports. Morgan Stanley increased their price target on Patterson Companies from $27.00 to $31.35 and gave the stock an “equal weight” rating in a research report on Tuesday, December 17th. Stifel Nicolaus cut their price target on Patterson Companies from $25.00 to $24.00 and set a “hold” rating on the stock in a research report on Thursday, December 5th. StockNews.com initiated coverage on shares of Patterson Companies in a research note on Tuesday. They set a “hold” rating on the stock. Leerink Partners reissued a “market perform” rating and set a $31.35 target price (up from $29.00) on shares of Patterson Companies in a research note on Wednesday, December 11th. Finally, Leerink Partnrs lowered shares of Patterson Companies from a “strong-buy” rating to a “hold” rating in a research note on Wednesday, December 11th. Eleven equities research analysts have rated the stock with a hold rating and one has given a buy rating to the stock. Based on data from MarketBeat, the company has an average rating of “Hold” and an average price target of $26.57.

Patterson Companies Trading Down 0.0 %

Shares of Patterson Companies stock opened at $31.12 on Tuesday. The firm has a market capitalization of $2.75 billion, a PE ratio of 18.20, a P/E/G ratio of 2.71 and a beta of 0.99. Patterson Companies, Inc. has a twelve month low of $19.45 and a twelve month high of $31.79. The firm’s 50-day moving average price is $30.98 and its 200 day moving average price is $25.73. The company has a current ratio of 1.37, a quick ratio of 0.76 and a debt-to-equity ratio of 0.34.

Patterson Companies Company Profile

Patterson Companies, Inc engages in the distribution of dental and animal health products in the United States, the United Kingdom, and Canada. The company operates through three segments: Dental, Animal Health, and Corporate segments. The Dental segment offers consumable products, including infection control, restorative materials, and instruments; basic and advanced technology and dental equipment; practice optimization solutions, such as practice management software, e-commerce, revenue cycle management, patient engagement solutions, and clinical and patient education systems.